氯碳头孢在中耳液中的浓度。
Loracarbef concentrations in middle ear fluid.
作者信息
Kusmiesz H, Shelton S, Brown O, Manning S, Nelson J D
机构信息
Department of Otorhinolaryngology University of Texas, Southwestern Medical Center, Dallas 75235.
出版信息
Antimicrob Agents Chemother. 1990 Oct;34(10):2030-1. doi: 10.1128/AAC.34.10.2030.
Abstract
Loracarbef concentrations in plasma and middle ear fluid (MEF) were measured in specimens obtained approximately 2 h after doses of 7.5 or 15 mg/kg. The mean +/- standard deviation concentrations in MEF were 2.0 +/- 2.6 mg/liter (48% of the concentration in plasma) after the smaller dose and 3.9 +/- 2.6 mg/liter (42% of the concentration in plasma) after the larger dose. With the larger dose, the concentrations in MEF were greater than the MIC for 90% of strains of the usual pathogens of acute otitis media tested in 16 of 17 specimens.
摘要
在给予7.5或15mg/kg剂量后约2小时采集的样本中，测定了血浆和中耳液（MEF）中的氯碳头孢浓度。较小剂量后，MEF中的平均浓度±标准差为2.0±2.6mg/升（血浆浓度的48%），较大剂量后为3.9±2.6mg/升（血浆浓度的42%）。使用较大剂量时，在17个样本中的16个样本中，MEF中的浓度高于所检测的16种急性中耳炎常见病原体90%菌株的最低抑菌浓度（MIC）。
相似文献
1
Loracarbef concentrations in middle ear fluid.氯碳头孢在中耳液中的浓度。
Antimicrob Agents Chemother. 1990 Oct;34(10):2030-1. doi: 10.1128/AAC.34.10.2030.
2
Penetration of ceftibuten into middle ear fluid.头孢布烯在中耳液中的渗透情况。
Antimicrob Agents Chemother. 1996 Jun;40(6):1394-6. doi: 10.1128/AAC.40.6.1394.
3
Pharmacokinetics of cefprozil in plasma and middle ear fluid: in children undergoing treatment for acute otitis media.头孢丙烯在血浆和中耳液中的药代动力学：急性中耳炎患儿治疗期间的研究
Paediatr Drugs. 2007;9(2):119-23. doi: 10.2165/00148581-200709020-00005.
4
Concentrations of antimicrobial agents in middle ear fluid, saliva and tears.中耳积液、唾液和泪液中抗菌剂的浓度。
Int J Pediatr Otorhinolaryngol. 1981 Dec;3(4):327-34. doi: 10.1016/0165-5876(81)90057-4.
5
Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media.阿莫西林、头孢克洛、红霉素 - 磺胺异恶唑及甲氧苄啶 - 磺胺甲恶唑在慢性浆液性中耳炎患者中耳液中的渗透情况。
J Infect Dis. 1982 Jun;145(6):815-21. doi: 10.1093/infdis/145.6.815.
6
Penetration of trimethoprim--sulfadiazine into middle ear fluid in secretory otitis media.
Int J Pediatr Otorhinolaryngol. 1983 Sep;6(1):89-94. doi: 10.1016/s0165-5876(83)80107-4.
7
Microdialysis studies of the distribution of antibiotics into chinchilla middle ear fluid.抗生素在豚鼠中耳液中分布的微透析研究。
Pharmacotherapy. 2005 Dec;25(12 Pt 2):140S-145S. doi: 10.1592/phco.2005.25.12part2.140S.
8
Pharmacokinetics of loracarbef in pediatric patients.
Eur J Drug Metab Pharmacokinet. 1992 Jul-Sep;17(3):201-4. doi: 10.1007/BF03190146.
9
Penetration of cefprozil into middle ear fluid of patients with otitis media.头孢丙烯在中耳炎患者中耳液中的渗透情况。
Antimicrob Agents Chemother. 1994 Sep;38(9):2210-2. doi: 10.1128/AAC.38.9.2210.
10
Penetration of cefpodoxime into middle ear fluid in pediatric patients with acute otitis media.
Pediatr Infect Dis J. 1997 Jan;16(1):79-81. doi: 10.1097/00006454-199701000-00020.
引用本文的文献
1
In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance.口服β-内酰胺类药物在人体所能达到的浓度下对青霉素敏感和耐药肺炎链球菌的体外活性及产生耐药性的可能性。
Antimicrob Agents Chemother. 1998 Aug;42(8):1973-9. doi: 10.1128/AAC.42.8.1973.
2
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.在体外药效学感染模型中头孢丙烯、青霉素、头孢克洛、头孢克肟和氯碳头孢对青霉素敏感及耐药肺炎链球菌的杀菌活性。
Antimicrob Agents Chemother. 1996 May;40(5):1148-52. doi: 10.1128/AAC.40.5.1148.
3
Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.氯碳头孢。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1993 May;45(5):716-36. doi: 10.2165/00003495-199345050-00008.
4
Clinical pharmacokinetics of newer cephalosporins.新型头孢菌素的临床药代动力学
Clin Pharmacokinet. 1995 May;28(5):361-84. doi: 10.2165/00003088-199528050-00003.
5
Bactericidal titers of loracarbef (LY 163892) in serum and killing rates in volunteers receiving 400 versus 200 milligrams.氯碳头孢（LY 163892）在血清中的杀菌效价以及接受400毫克与200毫克剂量的志愿者中的杀菌率。
Antimicrob Agents Chemother. 1992 Mar;36(3):521-6. doi: 10.1128/AAC.36.3.521.
6
Pharmaceutical properties of loracarbef: the remarkable solution stability of an oral 1-carba-1-dethiacephalosporin antibiotic.
Pharm Res. 1992 Feb;9(2):250-4. doi: 10.1023/a:1018949709797.
本文引用的文献
1
Penetration of amoxicillin, cefaclor, erythromycin-sulfisoxazole, and trimethoprim-sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media.阿莫西林、头孢克洛、红霉素 - 磺胺异恶唑及甲氧苄啶 - 磺胺甲恶唑在慢性浆液性中耳炎患者中耳液中的渗透情况。
J Infect Dis. 1982 Jun;145(6):815-21. doi: 10.1093/infdis/145.6.815.
2
Concentrations of antimicrobial agents in middle ear fluid, saliva and tears.中耳积液、唾液和泪液中抗菌剂的浓度。
Int J Pediatr Otorhinolaryngol. 1981 Dec;3(4):327-34. doi: 10.1016/0165-5876(81)90057-4.
3
Pharmacokinetics of LY163892 in infants and children.LY163892在婴幼儿和儿童中的药代动力学。
Antimicrob Agents Chemother. 1988 Nov;32(11):1738-9. doi: 10.1128/AAC.32.11.1738.
4
In vitro susceptibilities of common pediatric pathogens to LY163892.常见儿科病原体对LY163892的体外敏感性
Antimicrob Agents Chemother. 1988 Feb;32(2):268-70. doi: 10.1128/AAC.32.2.268.
Zotero 插件